MGX
#4303
Metagenomi Therapeutics, Inc. - Common Stock
1.3 2 USD
+0.04%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+3.94%
Monthly Change
+8.20%
6 month change
-8.33%
Year Change
-8.33%
Previous Close
1.2 7
Open
1.3 2
Low
1.3 2
High
1.3 2
Volume
3
Financials
- Market Capitalization 49.69 M
- Employee 118
- Founded 2016
- CEO N/A
- Website metagenomi.co
- Headquarter California, United States
- FIGI BBG00Y5ZXS77
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.69
Price to sales ratio
2.39
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4288 |  MREO Mereo BioPharma Group plc - American Depositary Shares | 0.32 USD | -5.88% | 0.00% | +3.23% | -81.50% | 51.08 M USD | ||
| 4290 |  TCRT Alaunos Therapeutics, Inc. - Common Stock | 2.08 USD | +1.46% | +1.96% | -12.24% | -22.07% | 50.80 M USD | ||
| 4306 |  INMB INmune Bio Inc. - Common stock | 1.86 USD | -4.12% | +11.38% | +47.62% | -12.68% | 49.45 M USD | ||
| 4309 |  ATYR aTyr Pharma, Inc. - Common Stock | 0.50 USD | -7.41% | -27.54% | +6.38% | -48.45% | 49.03 M USD |
Frequently asked questions about Metagenomi Therapeutics, Inc. - Common Stock
What is the Metagenomi Therapeutics, Inc. - Common Stock stock price today?
The current price of Metagenomi Therapeutics, Inc. - Common Stock (MGX) is 1.32. Over the past 24 hours, the stock has changed by +3.94%. Follow the MGX chart for real-time price dynamics.
What is the stock ticker of Metagenomi Therapeutics, Inc. - Common Stock?
Metagenomi Therapeutics, Inc. - Common Stock trades under the ticker MGX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Metagenomi Therapeutics, Inc. - Common Stock stock going up?
MGX has changed by +5.60% over the last week, +8.20% over the last month, and -8.33% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Metagenomi Therapeutics, Inc. - Common Stock net income for the last quarter?
Metagenomi Therapeutics, Inc. - Common Stock reported net income of -23.06 M for the last quarter. The previous quarter showed -22.53 M, which means net income changed by -2.36%.
How many employees does Metagenomi Therapeutics, Inc. - Common Stock have?
As of the latest available data, Metagenomi Therapeutics, Inc. - Common Stock has 118 employees. Workforce size can provide additional context about the company's scale and operations.
What is Metagenomi Therapeutics, Inc. - Common Stock EBITDA?
Metagenomi Therapeutics, Inc. - Common Stock EBITDA is -23.67 M, and its EBITDA margin is -1 896.79%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Metagenomi Therapeutics, Inc. - Common Stock stock?
You can buy Metagenomi Therapeutics, Inc. - Common Stock (MGX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Metagenomi Therapeutics, Inc. - Common Stock stock?
Investing in Metagenomi Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MGX chart and related analysis on metatrader.com as part of your research.